IL15 and neoplasm: Additionally, BiKEs and TriKEs have been designed to further boost CAR-NK cell activity by simultaneously targeting tumor antigens and engaging CD16 on NK cells, with TriKEs additionally delivering IL-15 to support NK cell persistence and proliferation [56,128].